These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Human T-lymphotropic virus type II and neurological disease. Araujo A; Hall WW Ann Neurol; 2004 Jul; 56(1):10-9. PubMed ID: 15236397 [TBL] [Abstract][Full Text] [Related]
45. Neurological aspects of HIV/human T lymphotropic virus coinfection. Tulius Silva M; de Melo Espíndola O; Bezerra Leite AC; Araújo A AIDS Rev; 2009; 11(2):71-8. PubMed ID: 19529747 [TBL] [Abstract][Full Text] [Related]
46. Seroepidemiology of the human retrovirus (HTLV/ATLV) in Okinawa where adult T-cell leukemia is highly endemic. Kohakura M; Nakada K; Yonahara M; Komoda H; Imai J; Hinuma Y Jpn J Cancer Res; 1986 Jan; 77(1):21-3. PubMed ID: 2870044 [TBL] [Abstract][Full Text] [Related]
47. Oncogenic retroviruses in animals and humans. Burmeister T Rev Med Virol; 2001; 11(6):369-80. PubMed ID: 11746999 [TBL] [Abstract][Full Text] [Related]
48. Ancient and modern retroviruses. Weiss RA Acta Microbiol Immunol Hung; 2000; 47(4):403-10. PubMed ID: 11056760 [TBL] [Abstract][Full Text] [Related]
49. The epidemiology and disease outcomes of human T-lymphotropic virus type II. Roucoux DF; Murphy EL AIDS Rev; 2004; 6(3):144-54. PubMed ID: 15595431 [TBL] [Abstract][Full Text] [Related]
50. Distribution of Human Immunodeficiency Virus and Human T-Leukemia Virus Co-infection in Bahia, Brazil. Pereira FM; Santos FLN; Silva ÂAO; Nascimento NM; Almeida MDCC; Carreiro RP; Galvão-Castro B; Rios Grassi MF Front Med (Lausanne); 2021; 8():788176. PubMed ID: 35083245 [TBL] [Abstract][Full Text] [Related]
51. Searching for Common Mammalian Retroviruses in Pediatric Idiopathic Diseases. Jeziorski E; Foulongne V; Ludwig C; Louhaem D; Rodiere M; Sitbon M; Courgnaud V Viruses; 2016 Mar; 8(3):86. PubMed ID: 27102168 [TBL] [Abstract][Full Text] [Related]
52. Retroviruses and opportunistic infection. An update. Johnson D Adv Nurse Pract; 2002 Jan; 10(1):69-70, 73, 90. PubMed ID: 12420515 [No Abstract] [Full Text] [Related]
53. Human retroviruses in the second decade: a personal perspective. Gallo RC Nat Med; 1995 Aug; 1(8):753-9. PubMed ID: 7585176 [TBL] [Abstract][Full Text] [Related]
54. Tumorigenesis related to retroviral infections. Braoudaki M; Tzortzatou-Stathopoulou F J Infect Dev Ctries; 2011 Nov; 5(11):751-8. PubMed ID: 22112727 [TBL] [Abstract][Full Text] [Related]
55. HTLV-1 and HIV-1 co-infection: A case report and review of the literature. Isache C; Sands M; Guzman N; Figueroa D IDCases; 2016; 4():53-5. PubMed ID: 27144124 [TBL] [Abstract][Full Text] [Related]
56. Increased prevalence of retrovirus infections among older women in Africa. Holmgren B; Aaby P; Jensen H; Larsen O; da Silva Z; Lisse IM Scand J Infect Dis; 1999; 31(5):459-66. PubMed ID: 10576124 [TBL] [Abstract][Full Text] [Related]
57. [Infection by HIV-2, HTLV and new human retroviruses in Spain]. Treviño A; Soriano V; Med Clin (Barc); 2012 May; 138(12):541-4. PubMed ID: 21565368 [No Abstract] [Full Text] [Related]
58. International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials. Murphy E; Jacobson S; Franchini G; Taylor GP; Hanchard B; Morgan O; Lairmore M Retrovirology; 2005 Mar; 2():22. PubMed ID: 15796774 [TBL] [Abstract][Full Text] [Related]
59. Biological basis for immunopharmacology in the control of early infection with human retroviruses. D'Onofrio C; Guerriero M; Bonmassar E Pharmacol Res; 1992 Sep; 26 Suppl 2():56-7. PubMed ID: 1329064 [No Abstract] [Full Text] [Related]
60. Cell Culture Evaluation Hints Widely Available HIV Drugs Are Primed for Success if Repurposed for HTLV-1 Prevention. Kalemera MD; Maher AK; Dominguez-Villar M; Maertens GN Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]